European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Monday Trading

MT Newswires Live
Yesterday

European equities traded in the US as American depositary receipts started the week slightly lower late Monday morning, declining 0.16% to 1,978.70 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet browser company Opera (OPRA) and consumer goods company Unilever (UL), which rose 1.9% and 1.8% respectively. They were followed by lender Banco Santander (SAN) and brewing company Anheuser-Busch InBev (BUD), which were up 1.2% and 1% respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and biotech firm BioNTech (BNTX), which dropped 5.1% and 4.2% respectively. They were followed by biopharmaceutical company argenx (ARGX) and telecommunications company Nokia (NOK), which were down 2.8% and 2.6% respectively.

The gainers from the UK were led by communications group WPP (WPP) and education company Pearson (PSO), which advanced 3.4% and 2.1% respectively. They were followed by alcoholic beverage company Diageo (DEO) and hospitality company Intercontinental Hotels Group (IHG), which increased 2% each.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which fell 5.5%. It was followed by biopharmaceutical company NuCana (NCNA) and biotech firm Autolus Therapeutics (AUTL), which lost 2% and 1% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10